The European Commission has cleared the acquisition of Millipore, US-based life science group, by German pharmaceutical and chemical company Merck.
The European Commission has cleared the acquisition of Millipore, US-based life science group, by German pharmaceutical and chemical company Merck. The $7.2 billion acquisition was announced in March and this approval keeps it on course for completion later this year.
The commission ruled that although the parties are both active in the life science business, they focus on different markets. In a statement they said that while Millipore supplies inputs for the research, development and production of biological drugs created through biological processes, Merck's inputs mainly serve in the research, development and production of products created through chemical processes. It concluded, “the transaction is largely complementary.”
For more information on the companies visit their websites, www.merck.de and www.millipore.com
Common Challenges in Nitrosamine Analysis: An LCGC International Peer Exchange
April 15th 2025A recent roundtable discussion featuring Aloka Srinivasan of Raaha, Mayank Bhanti of the United States Pharmacopeia (USP), and Amber Burch of Purisys discussed the challenges surrounding nitrosamine analysis in pharmaceuticals.
Extracting Estrogenic Hormones Using Rotating Disk and Modified Clays
April 14th 2025University of Caldas and University of Chile researchers extracted estrogenic hormones from wastewater samples using rotating disk sorption extraction. After extraction, the concentrated analytes were measured using liquid chromatography coupled with photodiode array detection (HPLC-PDA).